Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population

Apar Kishor P Ganti, Shanmuga P. Subbiah, Anne Kessinger, Wilson I. Gonsalves, Peter T. Silberstein, Fausto R. Loberiza

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98% were male, 82% had a smoking history, and 81% were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24% vs. 21%]; Grade I/II [21% vs. 17%]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48% vs. 41%; P <.001]; chemotherapy for stage IV [18% vs. 16%; P =.003]). African-American individuals had a lower risk of mortality compared with Caucasian individuals (hazard ratio, 0.94; 95% confidence interval, 0.92-0.96). Conclusion Although African-American patients had a higher stage and grade of NSCLC, they had a better overall survival than Caucasian patients. In a single-payer system with accessible health care, previously described racial differences in lung cancer outcomes were not observed.

Original languageEnglish (US)
Pages (from-to)152-158
Number of pages7
JournalClinical Lung Cancer
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2014

Fingerprint

Veterans
Non-Small Cell Lung Carcinoma
Survival
African Americans
Population
Single-Payer System
Delivery of Health Care
Registries
Lung Neoplasms
Smoking
History
Regression Analysis
Demography
Confidence Intervals
Drug Therapy
Mortality
Neoplasms

Keywords

  • Non-small-cell lung cancer
  • Outcomes
  • Prognosis
  • Race
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population. / Ganti, Apar Kishor P; Subbiah, Shanmuga P.; Kessinger, Anne; Gonsalves, Wilson I.; Silberstein, Peter T.; Loberiza, Fausto R.

In: Clinical Lung Cancer, Vol. 15, No. 2, 01.03.2014, p. 152-158.

Research output: Contribution to journalArticle

Ganti, Apar Kishor P ; Subbiah, Shanmuga P. ; Kessinger, Anne ; Gonsalves, Wilson I. ; Silberstein, Peter T. ; Loberiza, Fausto R. / Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population. In: Clinical Lung Cancer. 2014 ; Vol. 15, No. 2. pp. 152-158.
@article{d3e04d4dad194896b5641f68a2c78b12,
title = "Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population",
abstract = "Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98{\%} were male, 82{\%} had a smoking history, and 81{\%} were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24{\%} vs. 21{\%}]; Grade I/II [21{\%} vs. 17{\%}]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48{\%} vs. 41{\%}; P <.001]; chemotherapy for stage IV [18{\%} vs. 16{\%}; P =.003]). African-American individuals had a lower risk of mortality compared with Caucasian individuals (hazard ratio, 0.94; 95{\%} confidence interval, 0.92-0.96). Conclusion Although African-American patients had a higher stage and grade of NSCLC, they had a better overall survival than Caucasian patients. In a single-payer system with accessible health care, previously described racial differences in lung cancer outcomes were not observed.",
keywords = "Non-small-cell lung cancer, Outcomes, Prognosis, Race, Survival",
author = "Ganti, {Apar Kishor P} and Subbiah, {Shanmuga P.} and Anne Kessinger and Gonsalves, {Wilson I.} and Silberstein, {Peter T.} and Loberiza, {Fausto R.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.cllc.2013.11.004",
language = "English (US)",
volume = "15",
pages = "152--158",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population

AU - Ganti, Apar Kishor P

AU - Subbiah, Shanmuga P.

AU - Kessinger, Anne

AU - Gonsalves, Wilson I.

AU - Silberstein, Peter T.

AU - Loberiza, Fausto R.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98% were male, 82% had a smoking history, and 81% were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24% vs. 21%]; Grade I/II [21% vs. 17%]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48% vs. 41%; P <.001]; chemotherapy for stage IV [18% vs. 16%; P =.003]). African-American individuals had a lower risk of mortality compared with Caucasian individuals (hazard ratio, 0.94; 95% confidence interval, 0.92-0.96). Conclusion Although African-American patients had a higher stage and grade of NSCLC, they had a better overall survival than Caucasian patients. In a single-payer system with accessible health care, previously described racial differences in lung cancer outcomes were not observed.

AB - Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98% were male, 82% had a smoking history, and 81% were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24% vs. 21%]; Grade I/II [21% vs. 17%]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48% vs. 41%; P <.001]; chemotherapy for stage IV [18% vs. 16%; P =.003]). African-American individuals had a lower risk of mortality compared with Caucasian individuals (hazard ratio, 0.94; 95% confidence interval, 0.92-0.96). Conclusion Although African-American patients had a higher stage and grade of NSCLC, they had a better overall survival than Caucasian patients. In a single-payer system with accessible health care, previously described racial differences in lung cancer outcomes were not observed.

KW - Non-small-cell lung cancer

KW - Outcomes

KW - Prognosis

KW - Race

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84894052887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894052887&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2013.11.004

DO - 10.1016/j.cllc.2013.11.004

M3 - Article

C2 - 24361249

AN - SCOPUS:84894052887

VL - 15

SP - 152

EP - 158

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 2

ER -